Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Joliv
Mandate

Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Joliv

June 16, 2020 Employment and Benefits Banking and Finance Intellectual Property M&A IT, Telecommunications and Outsourcing

The Alfa eCare group is a recognized eHealth software company, providing solutions to both public and private healthcare providers throughout Sweden.

Joliv provides a range of eHealth solutions servicing over 120 clients primarily in the elderly care market. Joliv’s solutions contribute to a safe and quality-assured work environment for care providers with reduced administration needs and more time for personal meetings with patients. The strategic merge creates a one-stop-shop offering for the Swedish care market helping care providers and municipalities to further improve the quality of care provision.
 
Vinge’s team consisted of Filip Öhrner, Kristina Ekberg, Jesper Lindvall, Jonathan Riddersholm, Ellen Åkerdahl Flygt (M&A), Ebba Svenburg (Employment), Karl-Hugo Engdahl (Agreements and GDPR/IT), Stojan Arnerstål (IPR), Mikael Ståhl, Axel Jansson (Banking and Finance), Carl Bruneheim and Nathalie Hughes (VDR Assistants).

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025